Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by NIBBELINK, D. W.
Right arrow Articles by HENDERSON, W. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by NIBBELINK, D. W.
Right arrow Articles by HENDERSON, W. G.

(Stroke. 1975;6:622.)
© 1975 American Heart Association, Inc.


Intracranial Aneurysms and Subarachnoid Hemorrhage. A Cooperative Study. Antifibrinolytic Therapy in Recent Onset Subarachnoid Hemorrhage

DONALD W. NIBBELINK M.D.1; JAMES C. TORNER M.S.2; WILLIAM G. HENDERSON PH.D.2

1 Department of Neurology, University Hospitals Iowa City, Iowa 52242; Medical Affairs, Merck, Sharp & Dohme, West Point, Pennsylvania 19486
2 Department of Neurology, University Hospitals, Iowa City, Iowa 52242

Reprint requests should be addressed to: Aneurysm Registry, Department of Neurology, University of Iowa, Iowa City, Iowa 52242.

In this cooperative study among 13 institutions, 502 patients were treated with antifibrinolytic medication (epsilon-aminocaproic acid or tranexamic acid) within a 14-day period following rupture of an intracranial aneurysm. Mortality at the end of 14 days was 11.6%; proved rebleed rate was 12.7%. Patients with an internal carotid or anterior cerebral aneurysm had the highest mortality and rebleed rate. Most rebleeds occurred between the sixth and eleventh days following the initial bleed. Significantly higher mortality was reported among patients with cerebral vasospasm, yet rebleed rate was no different among those patients with or without vasospasm. The same pattern was observed among patients with a mean blood pressure value above and below 110 mm Hg. We conclude that antifibrinolytic therapy provides beneficial treatment to patients with recent onset Subarachnoid hemorrhage (SAH) following rupture of an intracranial aneurysm.


Key Words: tranexamic acid • ruptured intracranial aneurysm • epsilon-aminocaproic acid • cerebral vasospasm




This article has been cited by other articles:


Home page
Med Decis MakingHome page
R. A. McNutt and S. G. Pauker
Competing Rates of Risk in a Patient with Subarachnoid Hemorrhage and Myocardial Infarction: It's Now or Never
Med Decis Making, December 1, 1987; 7(4): 250 - 259.
[PDF]